AbbVie's (ABBV) Skyrizi Gets Nod for Psoriatic Arthritis in EU

Published on November 18, 2021

AbbVie (ABBV) secures approval in the EU for Skyrizi to treat adult patients with active psoriatic arthritis.

Continue reading on website
Other news

Duro drags hardware product development into the age of agile

November 18, 2021
To software developers, the process of creating a hardware product can seem distinctly 1980s. Even in the most high-tech of work flows, there are tons of error-prone and potentially expensive manual, steps including spreadsheets, confusion and a general feeling of the will to live sagging away through the musty, solder-stained floorboards of the hardware development shop. Along comes Duro and the

D or DUK: Which Utility Stock Should You Hold on to in 2022?

November 18, 2021
On the back of more robust fundamentals, Dominion Energy (D) seems better placed than Duke Energy (DUK) for the upcoming year.